Cellebrite DI (CLBT) Revenue (2020 - 2026)

Cellebrite DI has reported Revenue for 7 years, with the latest figure at $131.1 million in Q2 2026.

• On a quarterly basis, Revenue rose 15.77% year-over-year to $131.1 million in Q2 2026; TTM through Jun 2026 was $514.3 million, a 17.76% increase from a year earlier, with the FY2025 full-year figure at $475.7 million, up 18.56% from the prior year.
• Revenue was $131.1 million for Q2 2026 at Cellebrite DI, up from $128.3 million in the prior quarter.
• The five-year high for Revenue was $131.1 million in Q2 2026, with the low at $62.4 million in Q1 2022.
• Average Revenue over 5 years is $96.2 million, with a median of $94.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Revenue rose 5.75% in 2022, then gained 26.94% in 2024.
• Over 5 years, Revenue stood at $74.0 million in 2022, then rose by 25.66% to $93.0 million in 2023, then increased by 17.24% to $109.0 million in 2024, then grew by 18.13% to $128.8 million in 2025, then increased by 1.8% to $131.1 million in 2026.
• The last three Revenue figures came in at $131.1 million (Q2 2026), $128.3 million (Q1 2026), and $128.8 million (Q4 2025), per Business Quant data.